ERBB2 and cancer: Trastuzumab, a humanized monoclonal antibody, is widely used for the treatment of various cancers in humans including metastatic breast cancer and gastric cancer with over expression of cell surface human epidermal growth factor receptor 2 (HER2) receptors.